A MEDICATION SAFETY ACTION PLAN. Produced September 2014

Similar documents
Anti-Drug Strategy Initiative

Internet Connectivity Among Aboriginal Communities in Canada

Presentation to the Federal, Provincial and Territorial (FPT) Deputy Ministers of Health Meeting

Nova Scotia Public Reporting Serious Patient Safety events? Advancing Patient Safety & Quality?

Why is Critical Incident Reporting and Shared Learning Important for Patient Safety?

Canadian Hospital Experiences Survey Frequently Asked Questions

2014 New Building Canada Fund: Provincial-Territorial Infrastructure Component National and Regional Projects

Prescribing Standards for Nurse Practitioners (NPs)

Anesthesiology. Anesthesiology Profile

Context. Objectives. Hospital-based Pharmacy and Therapeutics Committees: Evolving Responsibilities and Membership

NCLEX-RN 2015: Canadian Results. Published by the Canadian Council of Registered Nurse Regulators (CCRNR)

NCLEX-RN 2016: Canadian Results. Published by the Canadian Council of Registered Nurse Regulators (CCRNR)

What Are the Key Ingredients in a Secret Sauce for Leadership Development?

Long Term Care Initiatives in Ontario. Kris Wichman Project Leader LTC June 2005

the BE Technical Report

Response to Proposed by-law amendment requiring members to obtain professional liability insurance

NCLEX-RN 2017: Canadian and International Results. Published by the Canadian Council of Registered Nurse Regulators (CCRNR)

Medical Assistance in Dying (Practitioner Administered) Practice Guideline for Pharmacists and Pharmacy Technicians

New Building Canada Fund: Provincial-Territorial Infrastructure Component National and Regional Projects

A Canadian Perspective of Baby Friendly Initiative & Nova Scotia, IWK Health Centre BFI Highlights

What Canadians Think Do we really know?

Nova Scotia Drug Information System

An Update. Pharmacy. Technician Regulation in Canada

Best Practices and Federal Barriers: Practice and Training of Healthcare Professionals

Standards. Prescribing Standards for Nurse Practitioners

STANDARDS OF PRACTICE 2018

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

MODEL STANDARDS OF PRACTICE FOR CANADIAN PHARMACISTS

Improving patient safety through disclosure and quality improvement reviews

National. British Columbia. LEADS Across Canada

Medical Assistance in Dying

Best Practices and Performance Measures for Systemic Treatment Computerized Prescriber Order Entry Systems (ST CPOE) in Chemotherapy Delivery

SPECIAL EDITION MARCH 2015 SPECIAL EDITION PHARMACY TECHNICIANS

2017 National Survey of Canadian Nurses: Use of Digital Health Technology in Practice Final Executive Report May, 2017

MARCH Progress timeline : Highlights of health care reform

PROVINCIAL-TERRITORIAL

CARING FOR OUR SENIORS. PEI review of the continuum of care for Island seniors

Partnering with Patients in Medication Safety

CNA s Governance Journey

Meet with preceptor monthly for 1 year. Preceptor to be approved by CPSO

Participant Information Name (optional)

Membership Survey Comparison Charts. Comparative Analysis 2015/2017

Required Organizational Practices Resources for 2016

1 Title Improving Wellness and Care Management with an Electronic Health Record System

ISMP Canada Workshop Medication safety: Incident analysis and prospective risk assessment

How do we know the surgical checklist is making a meaningful. impact in surgical care? Virginia Flintoft, MSc, BN Vancouver, BC March 9, 2010

To describe the process for the management of an infusion pump involved in an adverse event or close call.

Collaboration & Teamwork

Reuse of SUDs: Using Evidence to Inform Policy

Online Renewal Application 2018 Postgraduate Education

Medical Assistance in Dying

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Fair Registration Practices Report

CFPC Board of Directors Meeting Motions and Outcomes

The Regulation and Supply of Nurse Practitioners in Canada: 2006 Update

Guidance for Medication Reconciliation and System Integration Process

NATIONAL ASSOCIATION OF BOARDS OF PHARMACY (NAPB) / AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY (AACP) DISTRICT V MEETING THURSDAY, AUGUST 4, 2011

Medication Safety in LTC. Objectives. About ISMP Canada

SASKATCHEWAN ASSOCIATIO. Registered Nurse (Nurse Practitioner) Practice Standards RN(NP) Effective December 1, 2017

Review of the 10-Year Plan to Strengthen Health Care

How the Government of NS and Doctors NS work together to propel IM/IT

Preventing Medical Errors

E m e rgency Health S e r v i c e s Syste m M o d e r n i zation

A Collection of Referral and Consultation Process Improvement Projects

Patient Safety: 10 Years Later Why is Improvement So Hard? Patient Safety: Strong Beginnings

D DRUG DISTRIBUTION SYSTEMS

Access to Health Care Services in Canada, 2003

2018 PRE-BUDGET CONSULTATION

From Clinician. to Cabinet: The Use of Health Information Across the Continuum

Volunteers and Donors in Arts and Culture Organizations in Canada in 2013

Registration and Licensure as a Pharmacist

Proposed amendments to the Marihuana for Medical Purposes Regulations

About the PEI College of Pharmacists

Ministry of Health Patients as Partners Provincial Dialogue Report

SEIU-West submission to the Saskatchewan Government: Bill 179 Private MRIs in Saskatchewan. Barbara Cape, President

Safer Healthcare Now! Instructions for Data Entry and Submission Using Measurement Worksheets

Medication Management Checklist for Supportive Living Early Adopter Initiative. Final Report. June 2013

Statutory Regulation in Canada

Health Canada Safety Codes

Therapeutic Recreation Regulation in Canada 2015: Comparison of Canada s Health Professions Acts

There must be a clearly worded statement outlining the goals of the residency program and the educational objectives of the residents.

Mississauga Halton Local Health Integration Network (LHIN) Francophone Community Consultation - May 9, 2009

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Pediatrics. Pediatrics Profile

Data Quality Documentation, Hospital Morbidity Database

First Nations and Inuit Health Services Accreditation Community. Information. September 2014

Health Quality Ontario Business Plan

Safe Medication Practices

College of Nurses of Ontario. Membership Statistics Report 2017

MINISTRY OF HEALTH AND LONG-TERM CARE

Continuous Monitoring of Patients on Opioids: Capnography Initiative at BJC Healthcare. Friday October 14, 2016

MEDICATION SAFETY SELF-ASSESSMENT FOR LONG-TERM CARE ONTARIO SUMMARY. April 2009 September 2012

Manitoba Prescribing Practices Program Pharmacist Questions and Answers

Occupational Therapists in Canada, 2011 Database Guide

Health Challenges and Opportunities Delivered by The Honourable Doug Currie Minister of Health and Wellness

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Reducing the risk of serious medication errors in community pharmacy practice

Building a healthy legacy together. Presentation by Shelley Lipon, Executive Regional Director, Canada Health Infoway to ICTAM October 28, 2009

Making a case for medication reconciliation in primary care

Medication Safety in the Operating Room: Using the Operating Room Medication Safety Checklist

Transcription:

We are not, as a country, doing enough to ensure the safe use of medications. Medicine, in all its forms, is the most common treatment in health care and it works miracles every day when it s used appropriately. But when, as too often happens, a medication error is made, or a patient has a bad reaction to a treatment, the consequences can be terrible for individuals, their families and the health system. In Toronto in June of 2014, 37 health-care leaders met at a national summit to talk about improving medication safety in Canada. The meeting began with Fervid s story, told by her daughter-in-law Johanna Trimble. It was a compelling reminder of the impact that medications can have and a moving foundation for this important day. Definition: Medication safety is freedom from preventable harm with medication use 1 The summit, co-hosted by the Canadian Patient Safety Institute (CPSI) and the Institute for Safe Medication Practices Canada (ISMP Canada), is one of a series of meetings organized by CPSI as part of its 2013-2018 business plan to accelerate action on patient safety in Canada. The plan is for CPSI to act as a catalyst and secretariat for improving safety for patients through collaboration with other national organizations, multiple levels of government, patients, families, care providers and other stakeholders from across the country. Medication safety is one of the Forward with Four priority areas for this joint effort; the others are surgical safety, infection prevention and control, and home care. Medications are everywhere in health care, and with them, there are almost limitless potential for adverse events. There is a long list of grim facts and statistics detailing drug-related problems: Baker and Norton s Canadian Adverse Events Study (2004) found drug or fluid-related events were the second most common type of adverse events in Canadian hospitals, accounting for 23.6 per cent of the total. A 2008 study found that more than one in nine emergency-department visits were due to drug related adverse events, and 68 per cent of them were preventable. 2 Close to 25 per cent of patients involved in a medication adverse event died or suffered some other catastrophic event, according to the Canadian Medical Protective Association. Those details come from a scan of evidence on medication safety we did to prepare for the summit. It was distributed to people who were planning to attend, who were also asked to fill out a brief survey. The survey asked what their organization thought the top three concerns or gaps were in medication safety, its top three priorities for it, and what it believed patients and families would identify as their top three concerns. Finally participants were asked what key components, activities or mechanisms would be most important to you and your organization to include in the action plan? Answers ranged from calls to coordinate all the activities listed in the scan, to improving medication reconciliation processes, to advancing the use of digital tools to improve medication safety. At the meeting the ideas raised in the survey were talked about and voted on until five emerged as themes for discussion in the world café. They were: Reporting, learning and sharing Evidence-informed practices Partnering with patients, families and the public Education Technology A world café is a meeting model used to stimulate creative thinking in large groups. At the medication safety meeting, participants rotated among five world 1 ISMP Canada, 2007, available from: http://www.ismp-canada.org/ definitions.htm 2 Zed, P. et al. Incidence, serverity and preventability of medication-related visits to the emergency depart: a prospective study, CMAJ. 2008 June 3:178(12) 1563-9. * The Government of Quebec did not participated at the Medication Safety Summit. It is solely responsible for the planning, organization, management and evaluation of patient safety in Quebec. 2

café tables for 20 minutes at a time to discuss a total of three themes each. Here s some of what they had to say: Reporting, learning and sharing How do we create a bridge to get learnings really shared? -Participant Canada s systems for reporting medication-safety incidents are fairly robust, but our approach to sharing and learning is passive; alerts are posted on websites or distributed to limited audiences, and few busy people have hours to sift through notices of hazards, looking for any that might be relevant to them. Much discussion focused on the fact that although there are multiple systems for reporting medication incidents, there is no mechanism or program to allow people across the country to learn from adverse events. Participants agreed reporting alone does not change anything: what we need to make meaningful changes is a mechanism to share lessons and implement system changes to ensure the prevention of similar incidents. Evidence-Informed Practices The evidence-informed practice discussions ranged widely, but there was considerable talk about the value of developing and implementing evidence-informed guidelines for clinical practice to improve medication safety. However, participants agreed identifying guidelines does not ensure safer care; providers have to be persuaded to follow them. There was discussion of making the use of best-practice guidelines a requirement for accreditation, to encourage their use, as it has other safety practices, and participants identified several that could greatly improve the safety of medication use. One suggestion was to look at developing a strategy to make opioid use safer, which could include tools and resources already available. There were also calls to rethink medication reconciliation, by fully exposing the meaning of the concept to include what it really is communication about medication at all interfaces of care. If it were presented that way, it might resonate more with providers and consumers in all parts of the system. Partnering with patients Effective partnering is going to take work from both sides of the equation, because of the historical hierarchical relationship between providers and patients and families. We need to shift professional culture one participant said, in order to change providers attitudes and make them open to really sharing information with patients and families, Greater sharing, participants said, will also require public information campaigns and support for patients and their families to challenge health-care power structures and be active partners in medication safety. Providers also need to be equipped and ready to have difficult conversations they might rather avoid. Education Participants identified two education needs. Patients need better access to plain-language resources that explain medications and medication safety clearly. At the same time, it needs to be made clear to health-care providers that all members of interdisciplinary teams have roles to play in medication safety, and the roles individuals can and should play must be understood by all. Technology We are finding people are interpreting legislation much more narrowly than we ever intended. -Participant Information systems are essential for an integrated health system, but privacy concerns are overemphasized and a deterrent to implementing needed information technology, some participants said. Participants called for standard requirements to ensure vendors meet the needs of Canadian health care. People also wanted to see consumer portals as a mandatory feature in all patient-information systems, to encourage people to take an active role in managing their medications. The action plan: At some point you just need to do something. After the world café, another round of discussion and voting determined which items would be included in an action plan for medication safety. CPSI and ISMP Canada, in their roles as co-hosts, then drafted this plan, outlining short- and medium-term actions for achieving improvement in each theme. The plan includes deadlines and suggestions on who might get involved in each step; it has been circulated to all the participants for comment. 3

THEME REPORTING, LEARNING AND SHARING Develop a mechanism by which medication information and learning from different data sources can be shared effectively. Develop an environmental scan followed by a white paper to identify all reporting systems that could provide medication incident data to a central access point for sharing and learning. Establish an advisory group to oversee the development, planning, and testing required to meet this goal. System-wide adoption of a qualityimprovement approach to implementing error- prevention strategies based on what we learn from incident reports. Establish a quality-improvement approach to implement prevention strategies on defined and prioritized medication safety issues based on the shared learning. THEME EVIDENCE-INFORMED PRACTICES Make opioid use safer for Canadians. Explore collaborating with the National Pain Centre on guidelines for appropriate and safe use of opioids, and create a plan to work with partners to implement and evaluate the guidelines, which should include managing chronic pain in non-cancer patients. Work with the Canadian Centre on Substance Abuse to identify research-based priorities for improving opioid safety. Collaborate with academic detailing groups to improve prescribing practices for opioid therapy. 4 4

THEME EVIDENCE-INFORMED PRACTICES continued Make opioid use safer for Canadians. Work with the Canadian Centre on Substance Abuse to identify research-based priorities for improving opioid safety. Collaborate with academic detailing groups to improve prescribing practices for opioid therapy. Improve communication about medications at transitions in care. Convene a working group to rebrand MedRec as one component of medication safety, and develop a strategy to promote rebranded products and resources. Improve access to pharmacy services in rural and remote areas. Identify and profile successful use of telehealth/telepharmacy to support access to pharmacy services to rural and remote areas of Canada. Explore other solutions to improve access to pharmacist services in all areas of Canada. THEME PARTNERING WITH PATIENTS Improve communication about medication among providers and patients and families at transitions of care. Create and disseminate a national medication safety checklist for patients and families at transitions in care. THEME TECHNOLOGY Increase input from patients and providers in the development and use of technology to improve medication safety. Convene a working group to develop strategies for influencing third parties such as vendors, to include patients and providers in designing medication safety related technology. 5

THEME TECHNOLOGY continued Increase input from patients and providers in the development and use of technology to improve medication safety. Convene a working group to clarify privacy legislation, to allow maximum use of technology in improving medication safety without compromising confidentiality. Lobby for availability of integrated consumer portals so patients can access their health records. 6

MEDICATION SAFETY SUMMIT PARTICIPATING ORGANIZATIONS Accreditation Canada Association Québecoise des établissements de santé et de services sociaux Atlantic Health Quality and Patient Safety Collaborative BC Patient Safety & Quality Council Canada Health Infoway Canadian Agency for Drugs and Technologies in Health Canadian Anesthesiologists Society Canadian Association of Chain Drug Stores Canadian Association of Paediatric Health Centres Canadian Pharmacists Association Canadian Society of Hospital Pharmacists Health Canada Health Quality Council of Alberta Institute for Safe Medication Practices Canada Manitoba Institute for Patient Safety Ministry, Alberta Health Ministry, Manitoba Health Ministry, Nova Scotia Department of Health and Wellness Canadian Association of Provincial Cancer Agencies Ministry, Northwest Territories Department of Health and Social Services Canadian Home Care Association Ministry, Ontario Ministry of Health and Long Term Care Canadian Institute for Health Information Ministry, Prince Edward Island Health and Wellness Canadian Medical Association National Association of Pharmacy Regulatory Authorities Canadian Medical Protective Association Patients for Patient Safety Canada Canadian Nurses Association Royal College of Physicians and Surgeons of Canada Canadian Patient Safety Institute Safer Healthcare Now! College of Family Physicians of Canada * The Government of Quebec did not participated at the Medication Safety Summit. It is solely responsible for the planning, organization, management and evaluation of patient safety in Quebec. 7 7